Characteristic | Pyronaridine-artesunate | Artemether-lumefantrine |
---|---|---|
n = 355 | n = 180 | |
Male, n (%) | 177 (49.9) | 84 (46.7) |
Mean age, years (SD) [range] | 4.9 (2.5) [0.3–11] | 5.3 (2.5) [0.3–12] |
<1 year, n (%) | 12 (3.4) | 3 (1.7) |
1– < 5 years, n (%) | 148 (41.7) | 69 (38.3) |
5–12 years, n (%) | 195 (54.9) | 108 (60.0) |
Ethnicity, n (%) | ||
Black | 342 (96.3) | 172 (95.6) |
Asian/Oriental | 13 (3.7) | 8 (4.4) |
Mean weight, kg (SD) [range] | 16.3 (4.1) [6.0–24.8] | 17.1 (4.4) [7.2–24.9] |
Mean body mass index, kg/m2 (SD) [range] | 15.0 (2.2) [6.0–24.5] | 15.1 (2.3) [10.7–25.0] |
Geometric mean asexual parasites per μL | 18565.9 | 18798.3 |
(95% CI) | (16005.9, 21535.4) | (15243.1, 23182.7) |
Patients with gametocytes, n (%) | 43 (12.1) | 25 (13.9) |
Temperature, °C | 38.0 (1.1) [35.9–41.5] | 37.8 (1.1) [35.4–41.0] |
Fever at screening, n (%) | 230 (65.0) | 107 (59.4) |
No previous malaria infection, n (%) | 130 (36.7) | 59 (32.8) |
Malaria in last 12 months, n (%)a | ||
None | 143 (41.1) | 65 (36.7) |
1 | 65 (18.7) | 34 (19.2) |
2 | 56 (16.1) | 35 (19.8) |
>2 | 84 (24.1) | 43 (24.3) |